- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Alembic Pharmaceuticals Limited — Updates, 24-02-2026: Press Release
24-02-2026 | 02:29 pm
24-02-2026 | 02:29 pm
Alembic Pharma received US approval for Efinaconazole Topical Solution, a generic equivalent for onychomycosis. This product targets a US market estimated at over ₹4,150 Cr annually, positioning the company for significant revenue growth.
No comments yet. Be the first to comment!